Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis



Título del documento: Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis
Revista: Annals of hepatology
Base de datos: PERIÓDICA
Número de sistema: 000414232
ISSN: 1665-2681
Autors: 1
2
1
1
3
1
Institucions: 1Mayo Clinic, Division of Gastroenterology and Hepatology, Rochester, Minnesota. Estados Unidos de América
2Mayo Clinic, Division of Biomedical Statistics and Informatics, Rochester, Minnesota. Estados Unidos de América
3Arizona State University, Executive Vice Provost, Tempe, Arizona. Estados Unidos de América
Any:
Període: May-Jun
Volum: 13
Número: 3
Paginació: 384-389
País: México
Idioma: Inglés
Tipo de documento: Artículo
Enfoque: Analítico, descriptivo
Resumen en inglés Primary sclerosing cholangitis (PSC) is an idiopathic hepatobiliary disorder associated with an increased risk for cholangiocarcinoma (CCA) and a median survival time of 12 years. Reliable predictors of CCA and other major adverse events in PSC are currently lacking. Recently, serum IgE was found to be associated with CCA in a Japanese cohort of PSC patients. Our aim in this study was to determine whether IgE levels predict time to CCA, liver transplantation, or death in a Western (USA-based) cohort of PSC patients. Material and methods. Thirty-eight patients with PSC and IgE levels were identified and categorized into low or high IgE groups based on the sample median. Groups were compared with respect to clinical characteristics and adverse endpoint-free survival, and the association between IgE and endpoints was assessed with multivariate proportional-hazards models. Results. The median sample age at PSC diagnosis was 41 years, and median serum IgE level was 47.6 kU/L. Low and high IgE groups differed significantly only with respect to IgG subclasses, which were higher among the latter (p < 0.05). There were no significant differences in composite endpoint-free (p = 0.83) or CCA-free survival (p = 0.20). In multivariate analyses, only Mayo PSC risk score and MELD score were significant predictors of endpoint-free survival (p < 0.05). Conclusions. Serum IgE level is associated with several IgG subclass levels but not time to CCA, liver transplantation, or death among PSC patients in a USA-based cohort. While Mayo PSC risk score and MELD score can predict these outcomes, more specific predictors of CCA are needed
Disciplines Medicina
Paraules clau: Gastroenterología,
Inmunología,
Enfermedades autoinmunes,
Colangitis esclerosante primaria,
Colangiocarcinoma,
IgE,
Trasplante de hígado
Keyword: Medicine,
Gastroenterology,
Immunology,
Autoimmune diseases,
Primary sclerosing cholangitis,
Cholangiocarcinoma,
IgE,
Liver transplantation
Text complet: Texto completo (Ver PDF)